Annual report pursuant to Section 13 and 15(d)

Note 14 - Income Taxes - Deferred Tax Assets and Liabilities (Details)

v3.19.1
Note 14 - Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
Non-capital losses carried forward $ 9,280 $ 7,233
Research and development expenditures 887 887
Share issue costs 529 117
Patents and other 293 319
Accruals (97)
Property and equipment (6) (4)
Total deferred tax asset, net 10,886 8,552
Valuation allowance (10,886) (8,552)
Net deferred tax asset